Werewolf Therapeutics announces annual meeting voting results; directors elected and auditor ratified

Werewolf Therapeutics, Inc.

Stockholders elected Briggs Morrison and Michael Sherman as Class I directors for three-year terms ending in 2025.
Ratification of Deloitte & Touche as auditor for FY2022 passed with 23,945,185 votes for, 1,694 against, 12 abstain.
Broker non-votes on director elections totaled 3,626,970.
No other material proposals were presented at the meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.